Bio-Rad Laboratories (BIO) Depreciation & Amortization (CF) (2009 - 2017)

Bio-Rad Laboratories (BIO) reported Depreciation & Amortization (CF) of $35.4 million for Q3 2017, down 8.12% year-over-year from $38.5 million in Q3 2016, and down 4.49% quarter-over-quarter from $37.0 million in Q2 2017.

Bio-Rad Laboratories (BIO) Depreciation & Amortization (CF) (2009 - 2017) Analysis & Trends

Bio-Rad Laboratories (BIO) has 9 years of Depreciation & Amortization (CF) data on file, last reported at $35.4 million in Q3 2017.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Depreciation & Amortization (Qtr)
1 Abbott Laboratories 152.92 Bn 146.27 Bn 6.27 Bn 381.00 Mn
2 Stryker 119.50 Bn 116.62 Bn 3.81 Bn 120.00 Mn
3 Medtronic 102.71 Bn 94.54 Bn 5.76 Bn 749.00 Mn
4 Boston Scientific 69.72 Bn 68.51 Bn 3.61 Bn 351.00 Mn
5 Edwards Lifesciences 49.24 Bn 45.57 Bn 1.29 Bn 40.90 Mn
6 GE HealthCare Technologies 29.74 Bn 27.67 Bn 1.98 Bn 78.00 Mn
7 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
8 Dexcom 28.96 Bn 27.84 Bn 750.30 Mn 67.10 Mn
9 Steris 20.31 Bn 19.88 Bn 697.10 Mn 123.40 Mn
10 Bio-Rad Laboratories 7.70 Bn 6.13 Bn 309.40 Mn -

Historic Data

Download Data
DateValue
Sep 30, 2017 35.36 Mn
Sep 30, 2017 35.36 Mn
Jun 30, 2017 37.03 Mn
Jun 30, 2017 37.03 Mn
Mar 31, 2017 33.66 Mn
Mar 31, 2017 33.66 Mn
Sep 30, 2016 38.49 Mn
Sep 30, 2016 38.49 Mn
Jun 30, 2016 37.58 Mn
Jun 30, 2016 37.58 Mn
Mar 31, 2016 34.09 Mn
Mar 31, 2016 34.09 Mn
Sep 30, 2015 33.56 Mn
Sep 30, 2015 33.56 Mn
Jun 30, 2015 32.13 Mn
Jun 30, 2015 32.13 Mn
Mar 31, 2015 32.28 Mn
Mar 31, 2015 32.28 Mn
Sep 30, 2014 37.12 Mn
Sep 30, 2014 37.12 Mn